Stay updated on Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial
Sign up to get notified when there's something new on the Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial page.

Latest updates to the Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, indicating a small metadata update to the study record.SummaryDifference0.0%

- Check22 days agoChange DetectedThe Publications section now references 'Anticoagulants for people hospitalised with COVID-19: a rapid review' as the source, updating the wording of the cited Cochrane review. This reflects a bibliographic clarification rather than a substantive change to the study details.SummaryDifference0.0%

- Check29 days agoChange DetectedThe page now shows Revision: v3.5.3, replacing Revision: v3.5.2. This indicates a minor site release update without altering the study information.SummaryDifference0.0%

- Check43 days agoChange DetectedRevision: v3.5.2 was added and revision: v3.5.0 was removed, indicating a version update.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision: v3.5.0 was added. Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page now shows Revision: v3.4.3 and no longer shows Revision: v3.4.2.SummaryDifference0.0%

Stay in the know with updates to Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dociparstat for Severe COVID-19 High-Risk Adults Clinical Trial page.